S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 94.9 TWD -1.15% Market Closed
Market Cap: 11.3B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

SCI Pharmtech Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SCI Pharmtech Inc
Other Liabilities Peer Comparison

Comparables:
Y
3705
4746
1789
1795
1720

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Other Liabilities
NT$29.6m
CAGR 3-Years
14%
CAGR 5-Years
6%
CAGR 10-Years
6%
Y
YungShin Global Holding Corp
TWSE:3705
Other Liabilities
NT$484.1m
CAGR 3-Years
2%
CAGR 5-Years
18%
CAGR 10-Years
2%
Formosa Laboratories Inc
TWSE:4746
Other Liabilities
NT$118.4m
CAGR 3-Years
24%
CAGR 5-Years
1%
CAGR 10-Years
27%
ScinoPharm Taiwan Ltd
TWSE:1789
Other Liabilities
NT$24.8m
CAGR 3-Years
-33%
CAGR 5-Years
-21%
CAGR 10-Years
-9%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Other Liabilities
NT$732.5m
CAGR 3-Years
-6%
CAGR 5-Years
-29%
CAGR 10-Years
8%
Standard Chem & Pharm Co Ltd
TWSE:1720
Other Liabilities
NT$131.8m
CAGR 3-Years
-16%
CAGR 5-Years
-11%
CAGR 10-Years
-12%

See Also

What is SCI Pharmtech Inc's Other Liabilities?
Other Liabilities
29.6m TWD

Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Other Liabilities amounts to 29.6m TWD.

What is SCI Pharmtech Inc's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
6%

Over the last year, the Other Liabilities growth was 17%. The average annual Other Liabilities growth rates for SCI Pharmtech Inc have been 14% over the past three years , 6% over the past five years , and 6% over the past ten years .

Back to Top